Figure 8.

Effects of LMWC on the abundance of p-IκBα and IκBα protein in LPS-treated IPEC-J2 cells. (A) p-IκBα: phosphorylated inhibitor of nuclear factor-κB α. (B) IκBα: inhibitor of nuclear factor-κB α. Cells were pretreated with LMWC (400 μg/mL) for 2 h, followed by cotreatment with LPS (5 μg/mL) for another 6 h. Data are presented as the mean ± standard error (n = 4). * Means significant difference compared with the control group (p < 0.05). ^† Means significant difference compared with the LPS group (p < 0.05).